Coenzyme Q10 (COQ) in Huntington\'s Disease (2CARE)


The purpose of this research study is to assess the effect of Coenzyme Q10 (CoQ) on slowing the worsening of HD symptoms. Researchers will also assess the safety and the acceptability of CoQ in long-term use. The 2CARE study is designed and conducted by a group of clinical investigators and scientists, called the Huntington Study Group (HSG), which seeks to develop new treatments for Huntington\'s disease (HD).


Huntington\'s Disease, Huntington\'s Study Group , Coenzyme Q10, 2CARE Study

Principal Investigator

Ramon Rodriguez Cruz, Assistant Professor



Contact Information

Be an Informed Participant

Before deciding to participate in a research study, take time to learn about clinical research, how it's conducted and your rights as a research participant. Following are some helpful resources from independent sources. Always remember that a clinical research study is research, not treatment.

Know Who to Contact

  • Eligibility: For questions about a specific study and who is eligible to participate, call or email the contact person listed for that study.
  • Your Rights: For questions about your rights as a research participant, contact the UF Institutional Review Boards at 352-273-9600.
  • Feedback: For general questions or feedback about study listings, email the UF Clinical and Translational Science Institute at

Other Resources

  • Join a national registry of volunteers willing to be contacted about research studies.

For Research Teams